by The China scar treatment market has witnessed significant growth in the recent years owing to rising aesthetic consciousness among Chinese population. Scar treatment products aim to minimize the visibility of scars as well as improve their appearance and texture through processes like laser treatment, topical products, and surgical revisions. Scars are generally formed due to injuries, burns, acne, and post-surgical wounds.
The Global China Scar Treatment Market Demand is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period 2024 to 2030.
Scar treatment products help reduce appearance of scars and their discoloration. They also improve texture and thickness of scars. Rising incidence of road accidents, burns, and surgeries have increased demand for scar treatment in China. Additionally, increasing health and beauty consciousness has raised aesthetics needs. This has propelled growth of scar treatment market in the country.
Key Takeaways
Key players operating in the China scar treatment market are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. These players dominate the market with wide product portfolios and strong geographical presence.
The China scar treatment market provides numerous opportunities for players to expand their footprint. Increasing medical tourism and development of innovative products offer lucrative growth prospects. Furthermore, rising disposable incomes will drive demand for advanced yet costly scar treatment procedures in China.
Globally, the scar treatment market is witnessing rapid expansion driven by growing medical aesthetics industry. Market players are investing in R&D to develop more effective products with minimal invasive options. They are also focusing on Asia Pacific region for business expansion given rising medical needs and evolving healthcare infrastructure in the region.
Market Drivers
The key growth driver for China scar treatment market is rising aesthetic consciousness among Chinese population. Increased awareness about appearance and physical looks has boosted demand for scar revision procedures. Furthermore, high incidence of road accidents and burns in China necessitate scar treatment, supporting market growth.
PEST Analysis
Political: The scar treatment market in China is regulated by the China Food and Drug Administration. The authority lays down guidelines and standards for the approval and manufacturing of scar treatment products.
Economic: China has witnessed strong economic growth over the past decade which has increased disposable incomes and boosted healthcare spending. This favors growth of the cosmetic procedures market including scar treatments.
Social: Rising awareness about aesthetic procedures and the availability of new scar treatment options are driving the market. The social stigma around scars and desire for blemish-free skin is encouraging people to opt for scar treatments.
Technological: Advancements in lasers, injectables, and topical products are helping enhance the efficacy of scar treatments. New technologies like fractional lasers enable improved collagen remodeling for scar revision.
Geographical regions with high market concentration
China’s tier 1 cities like Beijing, Shanghai account for a major share of the scar treatment market value. This can be attributed to higher disposable incomes, access to advanced healthcare facilities and higher aesthetic awareness in these regions.
Fastest growing region
The scar treatment market is growing rapidly in tier 2 and tier 3 cities of China. Increased medical tourism, growing middle class and availability of low-cost treatment options are fueling market growth in cities like Chengdu, Shenyang and Guangzhou. The advent of day-care scar treatment centers is also increasing accessibility in smaller towns.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
